225 results on '"Scaradavou A"'
Search Results
2. Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation
3. Innovative Software Platform for Customized Clinical Transplant Guidelines Accelerates Library Expansion and Increases Clinician Utilization
4. Regulatory T Cell Reconstitution Is Associated with Acute Graft-Versus-Host Disease in Pediatric and Young Adult Hematopoietic Cell Transplant Recipients
5. High Progression-Free Survival with Low Relapse Rates after Double-Unit Cord Blood Transplantation in Patients with High-Risk AML
6. Model-Based Dosing of Anti-Thymocyte Globulin in Pediatric Allogeneic Hematopoietic Cell Transplantation Improves Survival Chances: Updated Results from the Single Arm Phase II Parachute-Trial Combined with Real-World Data
7. Real-World Analysis of 3,843 Unrelated Donors (URDs) for 455 Allograft Candidates Reveals Low URD Availability with Marked Racial/ Ethnic Disparities: Implications for Transplant Center & Registry Operations
8. Predictors for Recent Thymic Emigrant T Cell Reconstitution after Hematopoietic Cell Transplantation
9. Early CD4 and B Cell Immune Reconstitution As Predictors of Outcomes in T Cell Depleted Allogeneic Hematopoietic Cell Transplantation
10. Gender Disparities in Allograft Access Due to HLA-Sensitization in Multiparous Women:Implications for Evaluation of Female Patients for Alternative Donor Transplantation
11. Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations
12. An Optimized Search Prognosis Tool to Predict 8/8 HLA Allele-Matched Unrelated Donor Procurement
13. Impact of Rabbit Anti-Thymocyte Globulin (rATG) Exposure in Ex Vivo T-Cell Depleted Hematopoietic Cell Transplantation in Children and Young Adults
14. Clinical Outcomes and Salvage Therapies of Pediatric Patients with Progressive B-ALL Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy
15. Donor Derived Leukemia in a Recipient of Allogeneic Hematopoietic Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa
16. Busulfan Exposure Is Associated with Survival in Pediatric and Adult AML/MDS Patients Undergoing a CD34+ Selected Allogeneic Hematopoietic Cell Transplantation
17. Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation
18. Busulfan Exposure Is Associated with Survival in Pediatric and Adult AML/MDS Patients Undergoing a CD34+ Selected Allogeneic Hematopoietic Cell Transplantation
19. Donor Derived Leukemia in a Recipient of Allogeneic Hematopoietic Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa
20. Clinical Outcomes and Salvage Therapies of Pediatric Patients with Progressive B-ALL Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy
21. Guidelines for Cord Blood Unit Selection
22. Guidelines for Cord Blood Unit Thaw and Infusion
23. Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation
24. Unlicensed Umbilical Cord Blood Units Provide a Safe and Effective Graft Source for a Diverse Population: A Study of 2456 Umbilical Cord Blood Recipients
25. Evaluation of Cord Blood Total Nucleated and CD34+ Cell Content, Cell Dose, and 8-Allele HLA Match by Patient Ancestry
26. An Optimized Search Prognosis Tool to Predict 8/8 HLA Allele-Matched Unrelated Donor Procurement
27. Impact of Rabbit Anti-Thymocyte Globulin (rATG) Exposure in Ex Vivo T-Cell Depleted Hematopoietic Cell Transplantation in Children and Young Adults
28. Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation
29. Encouraging Outcomes after Unrelated Cord Blood Grafts for Post-Transplant Relapse in Pediatric Patients
30. Double Unit Cord Blood Transplantation Compares Favorably to T-Cell Depleted Matched Adult Donor Transplantation for the Treatment of Acute Leukemia Due to a Robust Protection Against Relapse
31. Creation of a New Search Prognosis Tool That Can Accurately Predict the Likelihood of Procuring an 8/8 HLA-Allele Matched Unrelated Donor (URD) in Patients of Both European and Non-European Ancestry
32. Racial Disparities in Access to Alternative Donor Allografts Persist in the Era of “Donors for All”
33. Inaccuracies in Assignment of Patient Race & Ethnicity Highlights the Necessity of Staff Training to Accurately Capture Ancestry: Implications for Alternative Donor Allografts & Cancer Care Delivery
34. Analysis of Disparities in Speed to BMT Referral & Allograft in 279 Adults with AML: Non-Europeans Have Delayed Referrals & Cord Blood Can Facilitate Prompt Transplantation Regardless of Ancestry
35. Persistent or New Cytopenias Are a Better Predictor of Relapse Than Routine Bone Marrow Aspirate Evaluations after Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Pediatric and Young Adult Patients
36. Analysis of Disparities in Speed to BMT Referral & Allograft in 279 Adults with AML: Non-Europeans Have Delayed Referrals & Cord Blood Can Facilitate Prompt Transplantation Regardless of Ancestry
37. Inaccuracies in Assignment of Patient Race & Ethnicity Highlights the Necessity of Staff Training to Accurately Capture Ancestry: Implications for Alternative Donor Allografts & Cancer Care Delivery
38. Anti-Thymocyte Globulin Exposure in CD34+T Cell Depleted Allogeneic Hematopoietic Cell Transplantation
39. Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes
40. Creation of a New Search Prognosis Tool That Can Accurately Predict the Likelihood of Procuring an 8/8 HLA-Allele Matched Unrelated Donor (URD) in Patients of Both European and Non-European Ancestry
41. Persistent or New Cytopenias Are a Better Predictor of Relapse Than Routine Bone Marrow Aspirate Evaluations after Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Pediatric and Young Adult Patients
42. T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Patients with Fanconi Anemia and MDS/AML at a Single Institution
43. Anti-Thymocyte Globulin Exposure in CD34+T Cell Depleted Allogeneic Hematopoietic Cell Transplantation
44. Guidelines for Cord Blood Unit Selection
45. Guidelines for Cord Blood Unit Thaw and Infusion
46. Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation
47. Cord Blood Unit (CBU) search and distribution to Transplant Centers (TC): real-life experience from the National Cord Blood Program (NCBP)
48. Evaluation of Cord Blood Total Nucleated and CD34+ Cell Content, Cell Dose, and 8-Allele HLA Match by Patient Ancestry
49. Unlicensed Umbilical Cord Blood Units Provide a Safe and Effective Graft Source for a Diverse Population: A Study of 2456 Umbilical Cord Blood Recipients
50. T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Patients with Fanconi Anemia and MDS/AML at a Single Institution
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.